Caio Haddad Franco
Therapeutics to Combat Multi-Drug Resistant Pathogens · Institut Pasteur de São Paulo
Biography
Caio H. Franco completed a PhD in Sciences (Major in Microbiology and Immunology) from the Federal University of São Paulo in 2018. The main research developed by C. Franco is in Cell Biology, Microbiology and Parasitology. His main activities are focused on the design and establishment of numerous high-content microscopy assays, performing large-scale screenings with libraries of small molecules/natural products, and phenotypic and genetic characterisation of drug-resistant pathogens. C. Franco investigated relevant factors for the infection of mammalian cells by S. aureus through microscopy-based genomic screenings; in addition, he dedicated himself to characterising the intracellular lifestyle of antibiotic-resistant bacterial strains. He was also the Principal Investigator of an Exploratory Project funded by FCT on the field of functional genomics scre
Education
PhD in Sciences (Major in Microbiology and Immunology) - Federal University of São Paulo, Brazil Bachelor’s degree in biotechnology engineering - São Paulo State University, Brazil
Recent Scopus Publications
- Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi In Vitro and In Vivo
- In vitro anti-trypanosoma cruzi activity of halophytes from southern portugal reloaded: A special focus on sea fennel (crithmum maritimum l.)
- On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors
- Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity
- Prospecting and Identifying Phyllanthus amarus Lignans with Antileishmanial and Antitrypanosomal Activity
Links
- ORCID https://orcid.org/0000-0003-2467-9401
- Google Scholar https://scholar.google.com/citations?user=4J5NBdAAAAAJ
- Scopus https://www.scopus.com/authid/detail.uri?authorId=55953470500